CATX Heidi Henson buys $100K worth of shares
Dec 07, 2024, 5:31 AM
3.91%
What does CATX do
Perspective Therapeutics, based in Seattle, is a biotechnology company focused on developing radiopharmaceuticals for cancer treatment using the alpha-emitting isotope 212Pb. Their programs for melanoma and neuroendocrine tumors are in Phase I/IIa trials.
Heidi Henson bought 25,975 shares of CATX on 4 December at $3.85 per share, worth a total of $100K. They now own 25,975 CATX shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.